As one of the world's most influential international medical exhibitions and conferences, the Florida International Medical Exhibition 2024 (FIME) unveiled in June. FIME is widely regarded as an indispensable annual event for medical device manufacturers as well as healthcare professionals and distributors in the Americas.
At this exhibition, DPM highlighted five independently developed imaging systems, all with FDA or CE certifications. Among them, D3800 stood out as the world's first optical 3D 4K fluorescence endoscope camera system. DPM showcased its latest advancements in molecular imaging technology by bringing the audience into an immersive, three-dimensional visual experience.
Throughout the exhibition, DPM’s cutting-edge technology attracted significant attention from industry experts and agents worldwide. Many visited our booth to experience the products firsthand and had in-depth discussions and consultations with the DPM team, expressing approval to DPM’s product range and service philosophy. Distributors also showed keen interest, suggesting DPM’s growing influence in the global medical device market and significant potential future business opportunities.
At FIME, DPM reaffirmed its core mission: “Empowering Precise Surgery, Elevating Patient Health.” We are dedicated to improving the surgical outcomes and prognosis for patients with cancer and other diseases. Looking forward, we will expand our technology applications while keeping to refine and optimize our product lines. We are committed to contributing to the future of precision medicine.
DPM, a high-tech enterprise originating from the Institute of Automation, CAS, has successfully transformed decades of our scientific research achievements into devices through intellectual property equity investment. Backed by strong laboratory technology, DPM has developed a series of fluorescence molecular imaging products independently, including fluorescence endoscopic imaging systems, fluorescence tracers and other molecular imaging equipment. We will continue to lead the way in the molecular imaging field.
Amidst rapid health industry progress, DPM is always dedicated to pushing boundaries in intelligent technology R&D and manufacturing. We invite collaboration to expand international networks, delivering excellence to medical professionals & patients and propelling medical device industry towards higher standards.
